|
|||||
|
|
Long‐term (52‐week) efficacy and safety of ipragliflozin add‐on therapy to insulin in Japanese patients with type 1 diabetes mellitus: An uncontrolled,open‐label extension of a phase III study |
|
| Authors: | Kohei Kaku Hiroyuki Isaka Taishi Sakatani Junko Toyoshima |
| Abstract: | |
| Keywords: | Insulin Sodium– glucose cotransporter 2 inhibitors Type 1 diabetes mellitus |